HighTower Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

HighTower Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-100	Closed	-$3K	–	3038
2020 Q3	$3K	Hold	100	–	–	﹤0.01%	2499
2020 Q2	$5K	Buy	+100	New	+$11.3K	﹤0.01%	2349
2019 Q1	–	Sell	-20,000	Closed	-$442K	–	2469
2018 Q4	$442K	Hold	20,000	–	–	﹤0.01%	1424
2018 Q3	$442K	Buy	20,000 +13,000	+186%	+$1.87M	﹤0.01%	1518
2018 Q2	$41K	Buy	+7,000	New	+$994K	﹤0.01%	2077

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

HighTower Advisors's GWPH Position: Q2 2021 in Review

HighTower Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 4,766 shares — an estimated $1.03M sold.

HighTower Advisors first reported a position in GWPH in Q3 2014 and held it in 24 quarters. The position peaked at $1.15M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

HighTower Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
HighTower Advisors sold 4,766 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.03M.
HighTower Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2014 and held it in 24 quarters.
HighTower Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.15M in Q2 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on HighTower Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.